http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3673917-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ec0c31f15b34f0b46ff9fe7f64ab607
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-16034
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-295
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-295
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
filingDate 2018-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d9b6e90060dacf0c52e4390f5a575dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef1e1bb16c1c6cac9f57ce56d8dded7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6583f5af5f1fbe195934103c398d8d2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fd88a4ff2d00eabbc2b4b79f4a1d5d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e5e33b3541ee322225580b772e5d6c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b02526a90fd37c57f1316252a08dff6
publicationDate 2020-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3673917-A1
titleOfInvention Norovirus vaccines
abstract The present invention provides immunogenic compositions, nucleic acid molecules and VLPs suitable as Norovirus vaccine candidates. Further provided are host cells for producing the biological material as well as methods for producing and/or purifying the immunogenic compositions and VLPs. Further provided is an immunogenic composition for use in methods of preventing/treating a Norovirus infection in a subject.
priorityDate 2018-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017191264-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017109211-A9
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017109222-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1939214-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3184118-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016203025-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018170603-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4766
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398631
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397425
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399382
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407902
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420

Total number of triples: 39.